My Learning Cart
?
Categories
Account

Which biotech firm launched a new platform in 2023 to accelerate the development

₹0.0
Login to Download
  • 📥 Instant PDF Download
  • ♾ Lifetime Access
  • 🛡 Secure & Original Content

What’s inside this PDF?

Question: Which biotech firm launched a new platform in 2023 to accelerate the development of personalized cancer vaccines?

Options:

  1. Moderna
  2. BioNTech
  3. CureVac
  4. Amgen

Correct Answer: BioNTech

Solution: 

BioNTech launched a new platform in 2023 aimed at accelerating the development of personalized cancer vaccines tailored to individual patients.

Which biotech firm launched a new platform in 2023 to accelerate the development

Practice Questions

Q1
Which biotech firm launched a new platform in 2023 to accelerate the development of personalized cancer vaccines?
  1. Moderna
  2. BioNTech
  3. CureVac
  4. Amgen

Questions & Step-by-Step Solutions

Which biotech firm launched a new platform in 2023 to accelerate the development of personalized cancer vaccines?
  • Step 1: Identify the year mentioned in the question, which is 2023.
  • Step 2: Look for a biotech firm that launched a new platform in that year.
  • Step 3: Find out what the purpose of the new platform is, which is to accelerate the development of personalized cancer vaccines.
  • Step 4: Confirm the name of the biotech firm that launched this platform, which is BioNTech.
No concepts available.
Soulshift Feedback ×

On a scale of 0–10, how likely are you to recommend The Soulshift Academy?

Not likely Very likely
Home Practice Performance eBooks